Free shipping on all orders over $ 500

Tirofiban

Cat. No. M3074

All AbMole products are for research use only, cannot be used for human consumption.

Tirofiban Structure
Synonym:

L700462; MK383

Size Price Availability Quantity
5mg USD 45  USD45 In stock
10mg USD 75  USD75 In stock
50mg USD 220  USD220 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tirofiban (L700462) is a selective and reversible platelet integrin receptor (Gp IIb/IIIa) antagonist that inhibits fibrinogen binding to this receptor and has antithrombotic activity. Tirofiban induces proliferation and migration on endothelial cell by inducing production of VEGF.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models Adult mongrel dogs
Formulation In saline
Dosages ~500 mg/kg
Administration I.P.
Chemical Information
Molecular Weight 440.6
Formula C22H36N2O5S
CAS Number 144494-65-5
Form Solid
Solubility (25°C) 1M HCl: 45 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lukasz Szarpak, et al. Tirofiban in emergency conditions

[2] Lisha Tang, et al. The Application of Tirofiban in the Endovascular Treatment of Acute Ischemic Stroke: A Meta-Analysis

[3] Scott D Nei, et al. Tirofiban in Suspected Left Ventricular Assist Device Pump Thrombosis

[4] Wei Li, et al. Intravenous tirofiban therapy for patients with capsular warning syndrome

[5] Ming Yang, et al. Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke

Related Integrin Products
MORF-627

MORF-627 is a selective, orally active inhibitor for integrin αvβ6 with an IC50 of 9.2 nM (measuring by human serum ligand binding assay). MORF-627 inhibits αvβ6-mediated TGF-β1 activation with an IC50 of 2.63 nM, inhibits SMAD2/3 phosphorylation with an IC50 of 8.3 nM.

Volociximab

Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs).

GSK 3008348 hydrochloride 

GSK 3008348 hydrochloride is a small molecule integrin αvβ6 antagonist.

HSDVHK-NH2

HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM).

LDV

LDV, a tripeptide, is a non-fluorescent analog of LDV-FITC.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tirofiban, L700462; MK383 supplier, Integrin, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.